期刊
MEDICINA-LITHUANIA
卷 59, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/medicina59030504
关键词
H; pylori; hyperhomocysteinemia; brain cortical thinning; neurodegeneration; Alzheimer's disease
Helicobacter pylori infection is a global burden affecting over 50% of the world's population. It is not only associated with gastric pathologies like peptic ulcers and gastric cancer, but also implicated in the development of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and/or glaucoma by inducing brain cortical thinning.
Helicobacter pylori infection consists a high global burden affecting more than 50% of the world's population. It is implicated, beyond substantiated local gastric pathologies, i.e., peptic ulcers and gastric cancer, in the pathophysiology of several neurodegenerative disorders, mainly by inducing hyperhomocysteinemia-related brain cortical thinning (BCT). BCT has been advocated as a possible biomarker associated with neurodegenerative central nervous system disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and/or glaucoma, termed as ocular Alzheimer's disease. According to the infection hypothesis in relation to neurodegeneration, Helicobacter pylori as non-commensal gut microbiome has been advocated as trigger and/or mediator of neurodegenerative diseases, such as the development of Alzheimer's disease. Among others, Helicobacter pylori-related inflammatory mediators, defensins, autophagy, vitamin D, dietary factors, role of probiotics, and some pathogenetic considerations including relevant involved genes are discussed within this opinion article. In conclusion, by controlling the impact of Helicobacter pylori-related hyperhomocysteinemia on neurodegenerative disorders might offer benefits, and additional research is warranted to clarify this crucial topic currently representing a major worldwide burden.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据